Related Experiment Videos
Abnormal expression of complement receptor (CR1) in IgA nephritis: increase in erythrocytes and loss on glomeruli in
Insights
Patients with IgA nephritis and high serum creatinine showed elevated erythrocyte complement receptor 1 (CR1) levels. Glomerular CR1 expression was defective in these patients, suggesting acquired factors contribute to CR1 abnormalities in renal disease.
Area of Science:
- Nephrology
- Immunology
- Complement System Biology
Background:
- Complement receptor 1 (CR1) plays a crucial role in the immune system, particularly in clearing immune complexes.
- Alterations in CR1 expression have been implicated in various autoimmune and renal diseases.
- Understanding CR1 dynamics in renal diseases is essential for diagnosing and managing kidney dysfunction.
Purpose of the Study:
- To investigate the levels and expression of complement receptor 1 (CR1) in erythrocytes and glomeruli of patients with renal diseases.
- To correlate CR1 expression with serum creatinine levels and disease severity in IgA nephritis and membranoproliferative glomerulonephritis.
- To explore the functional significance of altered CR1 in the context of renal pathology.
Main Methods:
- Quantification of erythrocyte CR1 molecules using an immunoradiometric assay with monoclonal antibodies.
- Immunofluorescence studies to assess glomerular CR1 staining in kidney biopsies.
- Assessment of CR1 cofactor activity in cleaving immune complex-bound C3b.
Main Results:
- Elevated erythrocyte CR1 levels were observed in IgA nephritis and membranoproliferative glomerulonephritis patients with high serum creatinine.
- Patients with normal serum creatinine had normal erythrocyte CR1 levels.
- A high frequency of negative glomerular CR1 staining was detected in IgA nephritis patients with elevated serum creatinine, despite normal CR1 function as a cofactor.
Conclusions:
- Disease-associated acquired factors likely contribute to the abnormal expression of CR1 in renal diseases.
- Elevated CR1 levels on erythrocytes and defective CR1 expression on glomeruli represent distinct manifestations of CR1 dysregulation in kidney disease.
- These findings highlight a potential role for CR1 abnormalities in the pathogenesis or progression of specific renal conditions.
Abstract:
The number of complement receptor for C3b (CR1) molecules in erythrocytes from patients with renal diseases was measured by an immunoradiometric assay using monoclonal antibodies against CR1. IgA nephritis patients with high serum creatinine value (Scr) showed markedly elevated levels of CR1, whereas patients with normal Scr had normal CR1 levels. A similar increase in CR1 number was observed in membranoproliferative glomerular nephritis with high Scr. CR1 of these patients functioned normally as a cofactor of C3b inactivator in cleaving immune complex-bound C3b. In contrast, a high frequency (5/6) of negative staining of glomerular CR1 was observed in IgA nephritis patients with high Scr by immunofluorescence study. We postulate that the disease-associated, acquired factors at least in part contribute to the abnormal expression of CR1: elevated levels in erythrocytes and defective expression on glomeruli.